Screener
Bristol-Myers Squibb BMY Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on the most recent quarter.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's current ratio?
- Bristol-Myers Squibb (BMY) reported current ratio of 1.5× in Q2 2026.
- How has Bristol-Myers Squibb's current ratio changed year-over-year?
- Bristol-Myers Squibb's current ratio increased by 26.9% year-over-year, from 1.2× to 1.5×.
- What is the long-term trend for Bristol-Myers Squibb's current ratio?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's current ratio has grown at a -4.5% compound annual growth rate (CAGR), from 1.6× to 1.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Bristol-Myers Squibb's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude